ECM1 and non-small cell lung carcinoma: In 2019, a significant increase of AHSG (Alpha-2-HS-glycoprotein) and ECM1 (extracellular matrix protein 1) in NSCLC (Non-small-cell lung cancer) patients compared to healthy controls was reported [73].